One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply
N Engl J Med
.
2019 Sep 12;381(11):e23.
doi: 10.1056/NEJMc1908492.
Authors
Richard E Chaisson
1
,
Ritesh Ramchandani
2
,
Susan Swindells
3
Affiliations
1
Johns Hopkins University School of Medicine, Baltimore, MD rchaiss@jhmi.edu.
2
Harvard University T.H. Chan School of Public Health, Boston, MA.
3
University of Nebraska Medical Center, Omaha, NE.
PMID:
31509690
DOI:
10.1056/NEJMc1908492
No abstract available
Publication types
Letter
Comment
MeSH terms
HIV
Humans
Isoniazid*
Rifampin / analogs & derivatives
Tuberculosis*
Substances
Isoniazid
Rifampin
rifapentine
Grants and funding
R21 MH083308/MH/NIMH NIH HHS/United States